NCT06678659
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06678659
Title A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer (DAHLIA)
Acronym DAHLIA
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Recursion Pharmaceuticals Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
City of Hope RECRUITING Duarte California 91010 United States Details
Cleveland Clinic RECRUITING Cleveland Ohio 44195 United States Details
SCRI Oncology Partners - PPDS RECRUITING Nashville Tennessee 37203 United States Details
START Mountain Region RECRUITING West Valley City Utah 84119 United States Details
Princess Margaret Cancer Centre RECRUITING Toronto Ontario M5G 1X6 Canada Details
McGill University Health Centre (MUHC) - The Montreal RECRUITING Québec H4A3J1 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field